1H-1,2,4-噻唑-1-丙腈 | 76686-83-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 1H-1,2,4-噻唑-1-丙腈
• 英文名称: 1,2,4-triazole-1-propanenitrile
• 英文别名: 1H-1,2,4-triazole-1-propanenitrile；3-(1H-1,2,4-triazole-1-yl)propanenitrile；3-(1H-1,2,4-triazol-1-yl)propanenitrile；3-(1,2,4-triazol-1-yl)propanenitrile
• CAS: 76686-83-4
• 化学式: C₅H₆N₄
• mdl: MFCD03727265
• 分子量: 122.129
• InChiKey: FSRNFKKSRMNQDG-UHFFFAOYSA-N

物化性质

• 熔点：
  119-120 °C(Solv: methanol (67-56-1))
• 沸点：
  115 °C(Press: 0.2 Torr)
• 密度：
  1.20±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.4
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  54.5
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  1H-1,2,4-噻唑-1-丙腈 在 sodium azide 作用下， 以 溶剂黄146 为溶剂， 反应 24.0h， 以48.5%的产率得到5-(2-(1,2,4-triazol-1-yl)ethyl)tetrazolate dihydrate
  参考文献：
  名称：

  A general design platform for ionic liquid ions based on bridged multi-heterocycles with flexible symmetry and charge

  摘要：

  开发了一种概念设计平台，用于制备具有可变杂环、桥联、对称性和电荷的新型离子液体，通过简单的烷基化、点击反应和离子液体化学方法实现，并以1-(2-(5-四唑基)乙基)-3-(5-1H-四唑基)甲基咪唑盐及其转化为室温离子液体作为阳离子或阴离子进行了验证。

  DOI：

  10.1039/c002861d
• 作为产物：
  描述：

  1H-1,2,4-三唑 、 丙烯腈 在 三乙胺 作用下， 以 甲苯 为溶剂， 以93.3%的产率得到1H-1,2,4-噻唑-1-丙腈
  参考文献：
  名称：

  A general design platform for ionic liquid ions based on bridged multi-heterocycles with flexible symmetry and charge

  摘要：

  开发了一种概念设计平台，用于制备具有可变杂环、桥联、对称性和电荷的新型离子液体，通过简单的烷基化、点击反应和离子液体化学方法实现，并以1-(2-(5-四唑基)乙基)-3-(5-1H-四唑基)甲基咪唑盐及其转化为室温离子液体作为阳离子或阴离子进行了验证。

  DOI：

  10.1039/c002861d

文献信息

• [EN] AZOLE METHYLIDENE CYANIDE DERIVATIVES AND THEIR USE AS PROTEIN KINASE MODULATORS<br/>[FR] DERIVES DE CYANURE D'AZOLE METHYLIDENE ET LEUR UTILISATION COMME MODULATEURS DE PROTEINE KINASE
  申请人：APPLIED RESEARCH SYSTEMS

  公开号：WO2003106455A1

  公开（公告）日：2003-12-24

  The present invention is related to azole derivatives notably for use as pharmaceutically active compounds, as well as to pharmaceutical formulations containing such azole derivatives. Said azole derivatives are modulators of the protein kinase signalling pathways, particularly the one involving c-Jun N-terminal kinase and/or Glycogen Kinase Synthase 3. The present invention is furthermore related to novel azole derivatives as well as to methods of their preparation. X is O, S or NR0, with R0 being H or an unsubstituted or substituted C1 -C6 alkyl; A is 2-pyridyl, 3-pyridyl, 4-pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl or triazinyl group.

  本发明涉及唑衍生物，尤其是用作药物活性化合物的唑衍生物，以及包含这种唑衍生物的药物制剂。所述唑衍生物是蛋白激酶信号通路的调节剂，尤其是涉及c-Jun N端激酶和/或糖原合酶3的那一种。本发明还涉及新颖的唑衍生物以及它们的制备方法。X是O、S或NR0，其中R0是H或未取代或取代的C1-C6烷基；A是2-吡啶基，3-吡啶基，4-吡啶基，吡啶唑基，吡唑啉基，吡嗪基或三嗪基团。
• Thromboxane synthetase inhibitors and antihypertensive agents. 1. N-[(1H-imidazol-1-yl)alkyl]aryl amides and N-[(1H-1,2,4-triazol-1-yl)alkyl]aryl amides
  作者：William B. Wright、Jeffery B. Press、Peter S. Chan、Joseph W. Marsico、Margie F. Haug、Judy Lucas、Jess Tauber、Andrew S. Tomcufcik

  DOI：10.1021/jm00154a017

  日期：1986.4

  formation. The most interesting thromboxane synthetase inhibitors prepared were 4-chloro-, 4-(trifluoromethyl)-, and 4-bromobenzamide derivatives of (1H-imidazol-1-yl)alkylamines with C5-C8 alkyl chains separating the heterocycle from the amide moiety, while the most active antihypertensive agents were 3- or 4-chloro-, -bromo, or -(trifluoromethyl)benzamides with C3 alkyl chains. The best thromboxane

  制备标题化合物以研究其作为血栓烷合成酶抑制剂以及降压药的潜力。制备咪唑VIII和三唑X以检查芳族取代，链长和杂环取代对生物活性的影响。咪唑VIII和三唑X是不抑制前列环素形成的血栓烷合成酶抑制剂。制备的最有趣的血栓烷合成酶抑制剂是（1H-咪唑-1-基）烷基胺的4-氯-，4-（三氟甲基）-和4-溴苯甲酰胺衍生物，其C5-C8烷基链将杂环与酰胺部分分开，而最具活性的降压药是带有C3烷基链的3-或4-氯-，-溴或-（三氟甲基）苯甲酰胺。
• An effective aza-Michael addition of aromatic amines to electron-deficient alkenes in alkaline Al2O3
  作者：Xin Ai、Xin Wang、Jin-ming Liu、Ze-mei Ge、Tie-ming Cheng、Run-tao Li

  DOI：10.1016/j.tet.2010.05.054

  日期：2010.7

  Aza-Michael addition of aromatic or aliphatic amines with various electron-deficient alkenes was performed using alkaline Al2O3 as solid media at room temperature afforded the corresponding Michael addition products in good to excellent yields. The alkaline Al2O3 can be easily recovered and reused.

  在室温下，使用碱性Al 2 O 3作为固体介质，对芳香族或脂肪族胺与各种缺电子的烯烃进行Aza-Michael加成反应，得到了相应的Michael加成产物，收率良好至极佳。碱性Al 2 O 3可以容易地回收和再利用。
• [EN] BENZOXAZOLE ACETONITRILES<br/>[FR] BENZOXAZOLE ACETONITRILES
  申请人：APPLIED RESEARCH SYSTEMS

  公开号：WO2005026159A1

  公开（公告）日：2005-03-24

  The present invention is related to benzoxazole acetonitriles as well as to pharmaceutical formulations containing such benzoxazole acetonitriles pof formula (I). Said benzoxazole acetonitriles are useful in the treatment of metabolic disorders mediated by insulin resistance or hyperglycernia, comprising diabetes type II, inadequate glucose tolerance, insulin resistance, obesity, polycystic ovary syndrome (PCOS). The present invention is furthermore related to methods of preparing benzoxazole acetonitriles (I). A is a pyrimidinyl.L is a secondary or tertiary amino group, or a 3-8 membered heterocycloalkyl, containing at least one heteroatom. selected from N, O, S or L is an acylarnino moiety.R1 is selected from the group comprising or consisting of hydrogen, sulfonyl, amino, CiC6-alkYl, C2-C6-alkenYl, C2-C6-alkynyl or Cl-C6-alkoxy, aryl, halogen, carboxy,aminocarbonyl, cyano or hydroxy.

  本发明涉及苯并噁唑乙腈，以及含有该苯并噁唑乙腈的药物配方（I）的制备方法。所述苯并噁唑乙腈在治疗由胰岛素抵抗或高甘油三酯引起的代谢紊乱方面具有用途，包括糖尿病II型、葡萄糖耐量不佳、胰岛素抵抗、肥胖、多囊卵巢综合征（PCOS）。A是嘧啶基。L是次级或三级氨基团，或者是含有至少一个来自N、O、S的杂原子的3-8环杂环烷基。R1选择自氢、磺酰基、氨基、CiC6-烷基、C2-C6-烯基、C2-C6-炔基、Cl-C6-烷氧基、芳基、卤素、羧基、氨基羰基、氰基或羟基。
• Michael Adducts in the Regioselective Synthesis of N-Substituted Azoles
  作者：András Horváth

  DOI：10.1055/s-1995-4054

  日期：1995.9

  Michael adducts of azoles (4-phenyl-, 4-methyl- and 4-nitroimidazole, 4-methylbenzimidazole, 1,2,4-triazole and theophylline) are shown to be valuable substrates for obtaining the N-substituted derivatives of the parent heterocycles by a quaternization-Hofmann elimination sequence. The effectiveness of the procedure is dependent on the regiochemical outcome of the first, N-protective step, i.e. the Michael addition. By choosing the appropriate Michael acceptor, alkylating agent and deprotection conditions, the thermodynamically less stable regioisomers of N-substituted azoles have been obtained in high yields.

  米哈伊尔加成物的偶氮物（4-苯基、4-甲基和4-硝基咪唑、4-甲基苯并咪唑、1,2,4-三唑和茶碱）被证明是获得母体杂环的N-取代衍生物的重要底物，这一过程通过一个季铵化-霍夫曼消除序列实现。该程序的有效性取决于第一个N保护步骤（即迈克尔加成）的区域化学结果。通过选择适当的迈克尔受体、烷基化试剂和去保护条件，可以以高产率获得N-取代偶氮物的热力学不太稳定的区域异构体。